Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High dose selenium after cardiac arrest
NCT01390506Phase 2Withdrawn
- Sponsor
- Medical University of Graz
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium selenite in cardiac arrest (SCA), sponsored by Medical University of Graz. Primary endpoint: neuron specific enolase at 72 hours. Planned start Jan 2017; status: withdrawn.
02
Drugs
sodium selenite
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT01390506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390506.